Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults

Purpose of Review To review the literature about oral pre-exposure prophylaxis (PrEP) for HIV prevention, with specific focus on adolescents. Recent Findings Use of PrEP reduces new HIV infections among men who have sex with men, heterosexuals, and people who inject drugs. One combination antiretrov...

Full description

Saved in:
Bibliographic Details
Published in:Current pediatrics reports (Philadelphia, PA) PA), 2018-06, Vol.6 (2), p.114-122
Main Authors: Mullins, Tanya L. Kowalczyk, Lehmann, Corinne E.
Format: Article
Language:English
Subjects:
Adolescent Medicine (M Goldstein and L Johnson
Medicine
Medicine & Public Health
Pediatrics
Section Editors
Topical Collection on Adolescent Medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of Review To review the literature about oral pre-exposure prophylaxis (PrEP) for HIV prevention, with specific focus on adolescents. Recent Findings Use of PrEP reduces new HIV infections among men who have sex with men, heterosexuals, and people who inject drugs. One combination antiretroviral medication is approved for PrEP in the USA for adults. Limited data suggest that PrEP is safe for use in youth, although declines in adherence to PrEP over time suggest the need for adherence interventions specifically targeting youth. Safety concerns related to PrEP include potential negative impacts on bone density and renal function, as well as potential increases in riskier sexual behaviors. The U.S. Public Health Service has published guidelines for PrEP use in adults. Summary Current data suggest that PrEP use is safe in adolescents; however, further research is needed on the potential impact of long-term PrEP use on bone density and kidney function.
ISSN:2167-4841
2167-4841
DOI:10.1007/s40124-018-0163-x